Animal vaccines have long been an effective way to reduce disease burden in pets and farm animals and are a key tool in maintaining animal health and welfare. The constant development of vaccines is essential with the rise in the emergence of different animal diseases. The global Animal Vaccines market is expected to grow at a sound pace in the times to follow.
The Animal Vaccines market is expected to experience considerable growth due to increasing pet ownership in developed countries and the rising number of cattle & poultry in developing countries. Furthermore, growing investment for R&D of vaccines is remarkably boosting the growth of the Animal Vaccines market. Additionally, the increasing prevalence of zoonotic diseases can negatively impact human lives, which is expected to propel the demand for animal vaccines. This fact further rises the growth of the market steadily.
However, lack of animal health awareness and the possibility of adverse impact on veterinary vaccines on human and other animal health hamper the growth of the Animal Vaccines market. Besides this, developments in vaccine products and the production of animal vaccines for hybrid animals provide new growth opportunities for the Animal Vaccines market.
Covid-19 Impact on Animal Vaccines Market
In addition, the current Animal Vaccines Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Animal Vaccines Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Animal Vaccines Market Segment Overview
According to the product, the Attenuated Vaccines segment has the maximum share of the Animal Vaccines market in 2020. Attenuated vaccines can provide stronger immunity as compared to other vaccines by activating an extensive range of immune responses. Moreover, it helps reduce the need for booster vaccines that can be administered via the oral route and induces long-lasting and rapid onset of immunity, which positively contributes toward the growth of the Animal Vaccines market.
Based on Animal Type, the Livestock animal segment contributed the maximum revenue in 2020 for the growth of the animal vaccines market. This is due to the increase in consumption of meat, milk, and dairy products, making sustainable animal health a vital aspect of disease management.
Animal Vaccines Market, By Product
· Attenuated Vaccines
· Inactivated Vaccines
· Subunit Vaccines
· Toxoid Vaccines
· Conjugate Vaccines
· Recombinant Vaccines
· DNA Vaccines
Animal Vaccines Market, By Animal Type
· Companion animal
· Livestock animal
Animal Vaccines Market Regional Overview
In terms of region, North America commanded a major share of the global Animal Vaccines market. This can be mainly attributed to the high adoption of companion animals, increasing consumption of meat and milk, and growing awareness regarding the benefits of using animal vaccines. Likewise, the Asia Pacific is expected to register the fastest growth during the forecast period. Important factors such as increasing pet ownership, rising incidence of various zoonotic diseases, and surge in investments in animal healthcare companies are remarkably supporting the growth of the Animal Vaccines market in this region.
Animal Vaccines Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Animal Vaccines Market, Key Players
· Merck & Co., Inc.
· Zoetis Inc.
· Ceva Santé Animale
· Sanofi S.A.
· Romvac
· Vaxxinova
· Biovac
· Boehringer Ingelheim GmbH
· Anicon Labor GmbH
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Animal Vaccines Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Attenuated Vaccines
- 5.2.2. Inactivated Vaccines
- 5.2.3. Subunit Vaccines
- 5.2.4. Toxoid Vaccines
- 5.2.5. Conjugate Vaccines
- 5.2.6. Recombinant Vaccines
- 5.2.7. DNA Vaccines
- 5.3. Market Analysis, Insights and Forecast – By Animal Type
- 5.3.1. Companion animal
- 5.3.2. Livestock animal
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America, Middle East and Africa
6. North America Animal Vaccines Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product
- 6.2.1. Attenuated Vaccines
- 6.2.2. Inactivated Vaccines
- 6.2.3. Subunit Vaccines
- 6.2.4. Toxoid Vaccines
- 6.2.5. Conjugate Vaccines
- 6.2.6. Recombinant Vaccines
- 6.2.7. DNA Vaccines
- 6.3. Market Analysis, Insights and Forecast – By Animal Type
- 6.3.1. Companion animal
- 6.3.2. Livestock animal
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Animal Vaccines Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product
- 7.2.1. Attenuated Vaccines
- 7.2.2. Inactivated Vaccines
- 7.2.3. Subunit Vaccines
- 7.2.4. Toxoid Vaccines
- 7.2.5. Conjugate Vaccines
- 7.2.6. Recombinant Vaccines
- 7.2.7. DNA Vaccines
- 7.3. Market Analysis, Insights and Forecast – By Animal Type
- 7.3.1. Companion animal
- 7.3.2. Livestock animal
- 7.4. Market Analysis, Insights and Forecast – By Country
- 7.4.1. UK
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Russia
- 7.4.7. Rest of Europe
8. Asia Pacific Animal Vaccines Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product
- 8.2.1. Attenuated Vaccines
- 8.2.2. Inactivated Vaccines
- 8.2.3. Subunit Vaccines
- 8.2.4. Toxoid Vaccines
- 8.2.5. Conjugate Vaccines
- 8.2.6. Recombinant Vaccines
- 8.2.7. DNA Vaccines
- 8.3. Market Analysis, Insights and Forecast – By Animal Type
- 8.3.1. Companion animal
- 8.3.2. Livestock animal
- 8.4. Market Analysis, Insights and Forecast – By Country
- 8.4.1. China
- 8.4.2. India
- 8.4.3. Japan
- 8.4.4. Australia
- 8.4.5. South East Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Animal Vaccines Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product
- 9.2.1. Attenuated Vaccines
- 9.2.2. Inactivated Vaccines
- 9.2.3. Subunit Vaccines
- 9.2.4. Toxoid Vaccines
- 9.2.5. Conjugate Vaccines
- 9.2.6. Recombinant Vaccines
- 9.2.7. DNA Vaccines
- 9.3. Market Analysis, Insights and Forecast – By Animal Type
- 9.3.1. Companion animal
- 9.3.2. Livestock animal
- 9.4. Market Analysis, Insights and Forecast – By Country
- 9.4.1. Brazil
- 9.4.2. Saudi Arabia
- 9.4.3. UAE
- 9.4.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Merck & Co., Inc.
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Zoetis Inc.
- 10.6. Ceva Santé Animale
- 10.7. Sanofi S.A.
- 10.8. Romvac
- 10.9. Vaxxinova
- 10.10. Biovac
- 10.11. Boehringer Ingelheim GmbH
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
